Chlorthalidone and hydrochlorothiazide are closely matched on safety, and the largest head-to-head trial found no difference in heart attacks, strokes, or death between the two. Chlorthalidone lowers blood pressure more effectively, but it also carries a slightly higher risk of dropping your potassium to unhealthy levels. The “safer” choice depends on your individual health profile, particularly your kidney function and electrolyte balance.
Cardiovascular Safety Is Nearly Identical
The Diuretic Comparison Project (DCP), a large Veterans Affairs trial, directly compared the two drugs in older adults with high blood pressure. The rate of major cardiovascular events (heart attack, stroke, or cardiovascular death) was 10.4% with chlorthalidone and 10.0% with hydrochlorothiazide. That difference was not statistically meaningful. For the vast majority of patients, neither drug is more dangerous to the heart than the other.
One interesting signal did emerge: among patients who had already experienced a heart attack or stroke before the trial, chlorthalidone appeared to offer a 27% lower risk of another cardiovascular event. Researchers flagged this as a hypothesis worth further study rather than a firm conclusion, since the overall trial showed no difference.
Chlorthalidone Lowers Blood Pressure More
A systematic review and meta-analysis published in the World Journal of Cardiology found that chlorthalidone reduces systolic blood pressure (the top number) by about 5 mmHg more than hydrochlorothiazide and diastolic pressure (the bottom number) by about 3 mmHg more. Those gaps are consistent across multiple studies and are statistically significant.
This stronger effect comes partly from how the two drugs behave in your body. Chlorthalidone has a half-life of 45 to 60 hours, meaning it stays active far longer than hydrochlorothiazide, which clears your system in roughly 6 to 15 hours. Chlorthalidone’s effects on blood pressure last 48 to 72 hours, giving it steadier 24-hour coverage. That longer action is a double-edged sword: it controls blood pressure more reliably, but it also means side effects can linger longer if they occur.
Potassium Loss: The Key Safety Difference
Low potassium (hypokalemia) is the most clinically important safety gap between the two. In the DCP trial, 8.9% of patients on chlorthalidone developed low potassium compared with 6.9% on hydrochlorothiazide. That roughly 2-percentage-point difference was statistically significant. Low potassium can cause muscle cramps, weakness, and in severe cases, dangerous heart rhythm problems.
Both drugs require regular blood work to monitor potassium levels, but chlorthalidone demands a bit more vigilance. If you’re already prone to low potassium, are taking other medications that deplete it, or have a condition that makes electrolyte shifts risky, your doctor may lean toward hydrochlorothiazide or add a potassium-sparing strategy alongside chlorthalidone.
Metabolic Side Effects Are Similar
Both medications belong to the thiazide diuretic family, and they share a common set of metabolic side effects. Patients taking either drug may see modest increases in blood sugar, uric acid, and certain cholesterol levels. Both have been associated with a higher risk of developing diabetes compared with other classes of blood pressure medication, though research suggests the majority of diabetes cases diagnosed during thiazide use are not actually caused by the diuretic itself.
Elevated uric acid is another shared concern. Higher uric acid levels can trigger gout flares and may contribute to kidney stress over time. Neither drug has a clear advantage here, as the metabolic profiles are similar enough that researchers have been unable to reliably separate them in pooled analyses.
Kidney Function Matters for Choosing
If your kidneys aren’t working at full capacity, the two drugs are not interchangeable. Hydrochlorothiazide is generally thought to lose its blood-pressure-lowering ability when kidney filtration (measured as eGFR) drops below about 45. Chlorthalidone continues working at lower levels of kidney function, remaining effective down to an eGFR of around 30. European hypertension guidelines now recommend chlorthalidone as a preferred option for patients with advanced chronic kidney disease and resistant high blood pressure, with evidence supporting its use even at eGFR levels as low as 15.
For people with healthy kidneys, this distinction won’t matter. But for the millions of adults with moderate to advanced kidney disease, chlorthalidone may be the only thiazide-type option that still meaningfully lowers blood pressure.
Dosing Is Not One-to-One
An important detail when comparing these drugs: they are not milligram-for-milligram equivalent. Chlorthalidone is roughly 1.5 to 2 times as potent as hydrochlorothiazide at the same dose. A common study comparison matches 25 mg of chlorthalidone against either 25 mg or 50 mg of hydrochlorothiazide, depending on whether researchers assume a 1:1 or 1:2 potency ratio. Chlorthalidone is typically available as 25 mg and 50 mg tablets, while hydrochlorothiazide comes in 12.5 mg, 25 mg, and 50 mg forms.
This potency difference means that some of chlorthalidone’s apparent superiority in blood pressure lowering, and some of its higher side-effect rates, may partly reflect the fact that patients are effectively getting a stronger dose. When studies try to account for this by using the 1:2 ratio (comparing 25 mg chlorthalidone to 50 mg hydrochlorothiazide), the differences between the drugs narrow.
How to Think About the Choice
Neither drug is categorically safer than the other. Hydrochlorothiazide has a slight edge in electrolyte safety, with about 2% fewer patients experiencing low potassium. Chlorthalidone has a stronger and longer-lasting blood pressure effect, which can itself be protective. Both carry the same metabolic risks, and neither causes more heart attacks or strokes than the other.
The practical tradeoffs break down along a few lines. Chlorthalidone may be the better fit if you need tighter blood pressure control, have reduced kidney function, or have a history of heart attack or stroke. Hydrochlorothiazide may be preferable if you’re sensitive to potassium loss, take other medications that lower potassium, or do well on a lower-intensity diuretic. In the United States, hydrochlorothiazide is prescribed far more often, partly out of habit and partly because of its milder side-effect profile at commonly used doses.